This federal contract award, valued at $27,555.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ANDEXXA 200 MG VIALS, a medical product, with a completion date of January 6, 2025.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
The contract award was not designated with a set-aside requirement, indicating open competition. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.
Generated 3/13/25, 9:45 AM